DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Mannose is an investigational drug.
There have been 28 clinical trials for Mannose. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2019.
The most common disease conditions in clinical trials are Infection, Urinary Tract Infections, and Communicable Diseases. The leading clinical trial sponsors are Renovo, Shire, and Enzon Pharmaceuticals, Inc.
Recent Clinical Trials for Mannose
|Phase II Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions and Cardiovascular Atherosclerosis.||Universitair Ziekenhuis Brussel||Phase 2|
|Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma||John O. Prior||Early Phase 1|
|Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)||Johns Hopkins University||Phase 2|